Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 15, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Global AI in Pathology Market Poised for Phenomenal Expansion at a CAGR of ~25% by 2034 | DelveInsight

New York, USA, July 15, 2026 (GLOBE NEWSWIRE) -- Global AI in Pathology Market Poised for Phenomenal Expansion at a CAGR of ~25% by 2034 | DelveInsight The AI in pathology market is witnessing...
July 14, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Tuberculosis Clinical Trial Pipeline Shows Potential with Active Contributions from 28+ Key Companies | DelveInsight

New York, USA, July 14, 2026 (GLOBE NEWSWIRE) -- Tuberculosis Clinical Trial Pipeline Shows Potential with Active Contributions from 28+ Key Companies | DelveInsight The tuberculosis clinical trial...
July 13, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight

New York, USA, July 13, 2026 (GLOBE NEWSWIRE) -- Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of...
June 25, 2026 13:00 ET | Source: DelveInsight Business Research LLP

IgA Nephropathy Clinical Trial Space Intensifies with 25+ Companies in Active Development | DelveInsight

New York, USA, June 25, 2026 (GLOBE NEWSWIRE) -- IgA Nephropathy Clinical Trial Space Intensifies with 25+ Companies in Active Development | DelveInsight The IgA nephropathy clinical trial analysis...
June 24, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Global HPV Vaccines Market to Grow Rapidly at a CAGR of ~8% by 2034 | DelveInsight

New York, USA, June 24, 2026 (GLOBE NEWSWIRE) -- Global HPV Vaccines Market to Grow Rapidly at a CAGR of ~8% by 2034 | DelveInsight The HPV vaccines market is witnessing significant growth due to...
June 23, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Acute Kidney Injury Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

New York, USA, June 23, 2026 (GLOBE NEWSWIRE) -- Acute Kidney Injury Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...
June 22, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Cutaneous Lupus Erythematosus Market to Expand at a CAGR of 8% During the Forecast Period (2026–2036) Amid Emerging Therapies and Increasing Healthcare Investments | DelveInsight

New York, USA, June 22, 2026 (GLOBE NEWSWIRE) -- Cutaneous Lupus Erythematosus Market to Expand at a CAGR of 8% During the Forecast Period (2026–2036) Amid Emerging Therapies and Increasing...
June 18, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Global Cell and Gene Therapy CDMO Market Anticipating Remarkable Growth at a CAGR of ~24% by 2034 | DelveInsight

New York, USA, June 18, 2026 (GLOBE NEWSWIRE) -- Global Cell and Gene Therapy CDMO Market Anticipating Remarkable Growth at a CAGR of ~24% by 2034 | DelveInsight The cell and gene therapy CDMO...
June 18, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Age-related Macular Degeneration Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 90+ Leading Players Wheeling the Therapeutics Landscape

New York, USA, June 18, 2026 (GLOBE NEWSWIRE) -- Age-related Macular Degeneration Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 90+ Leading Players...
June 16, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Glioblastoma Clinical Trial Landscape Expands: Over 200 Companies Advancing Next-Generation Therapies | DelveInsight

New York, USA, June 16, 2026 (GLOBE NEWSWIRE) -- Glioblastoma Clinical Trial Landscape Expands: Over 200 Companies Advancing Next-Generation Therapies | DelveInsight The glioblastoma clinical trial...